Pemigatinib is a therapeutic drug targeting specific types of cancer, indicated for the treatment of adult patients with metastatic or unresectable cholangiocarcinoma. It was launched in Mainland China in April 2022 but has not yet been included in China's national medical insurance scheme. The Lucius (Laos) version of pemigatinib comes in a specification of 4.5mg*14 tablets, with a price of 124 US dollars per box.

How Much Does Pemigatinib Cost?

Understanding the purchase price of pemigatinib helps patients plan their treatment costs rationally.

Market Price Fluctuations

The market price of pemigatinib may fluctuate due to changes in supply and demand, adjustments in production costs, and policy changes. When purchasing the drug, patients and their families should pay attention to market trends and obtain the latest price information to make reasonable decisions on drug purchase.

Price Differences Between Versions

Boke Long Pharmaceutical (Paraguay) version: Specification of 4.5mg*21 capsules, priced at 391 US dollars per box.

Lucius (Laos) version: Specification of 4.5mg*14 tablets, priced at 124 US dollars per box.

Hong Kong (China) version (also referred to as "Pemigatinib"): Specification of 13.5mg*14 tablets, priced at 9,536 US dollars per box.

The above prices are for reference only, and patients can choose according to their own circumstances.

How Effective Is Pemigatinib in Treatment?

The therapeutic effect of pemigatinib has attracted much attention. Understanding its efficacy helps patients and doctors develop more reasonable treatment plans.

Support from Clinical Trial Data

Clinical trial data of pemigatinib show that it performs excellently in the treatment of specific cancer types. By inhibiting the growth and spread of cancer cells, pemigatinib can help patients extend their survival period and improve their quality of life. The success of clinical trials provides strong support for the clinical application of pemigatinib.

Patient Feedback and Case Sharing

Many patients have reported positive therapeutic effects after using pemigatinib. They stated that the drug can effectively control the disease, alleviate symptoms, and improve the quality of life.

Comparison with Similar Drugs

Pemigatinib also shows certain advantages when compared with similar drugs. It has better targeting, lower toxic and side effects, and a wider range of indications. These characteristics make pemigatinib more competitive in clinical application.

What Is the Dosage and Administration of Pemigatinib?

Correct dosage and administration are crucial to the therapeutic effect of pemigatinib. Patients should strictly follow the doctor’s guidance and take the drug on time and in the prescribed dosage.

Administration Frequency and Treatment Course

The administration frequency and treatment course of pemigatinib are also important factors affecting the therapeutic effect. Patients should take the drug regularly as required by the doctor and complete the specified treatment course. Do not stop taking the drug or change the administration frequency at will, as this may affect the therapeutic effect.

Precautions and Management of Side Effects

When using pemigatinib, patients should also pay attention to certain precautions, such as avoiding concurrent use with other drugs and conducting regular monitoring of liver and kidney functions. If side effects occur, patients should contact the doctor in a timely manner to seek professional advice on management. Doctors will adjust the medication plan or take other measures to alleviate side effects according to the patient’s specific situation.

While using pemigatinib rationally, patients should also maintain a positive attitude, cooperate with the doctor’s treatment recommendations, and work together to combat the disease.